Communicare Intervention Assessment

Internal Characteristics

What are the characteristics of your health center? (rural/urban; other demographic variables, use of expanded care team, culture)?  

How do interventions and/or workflows need to be adapted to ensure health equity?

How complex are the patient interventions to implement (e.g., perceived difficulty of implementation, reflected by duration, scope, radicalness, disruptiveness, and number of steps required)?

What are key characteristics of the participating setting(s)?

External Characteristics

What external or environmental supports or threats are there?

Plan

Actual

Describe Intervention

Chosen intervention: YouTube video – getting on iPads or terminals in each exam room for videos only or getting link to patients to watch on smartphones (Spanish and English versions) 

PHAS Year 4 Statin Tool Testing.docx

Plan for intervention: : using the same YouTube video will expand to SpSp version. We will initiate beyond pilot team at Davis site (DCC) to all DCC teams starting Dec 2023 and then all provider teams at the other original CCHC sites by Mar 2024.

Chosen Intervention:

Date when implemented:

Updates:

Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention)

Reach of implementers/providers?

Planned: All Providers, all sites

Reach of implementers/providers?

Actual:

Reach of patients?

Planned: one site 8 to 10 pts a day to start with 

Reach of patients?

Actual:

Efficacy (Impact of intervention on important outcomes)

How will you measure that your intervention is working? ? --Survey for patients – tool influence understanding their risk and willingness to initiate or continue statin RX? 

--Did prescribing increase for patients who received the tool? 

Were you able to accurately measure how your intervention was working?

What outcomes do you expect? Increase patient education and engagement. Patients that watch the video will decide to get on a statin. influence understanding their risk and willingness to initiate or continue statin RX

What outcomes have you seen?

How will you ensure your intervention will be effective for your target population?

Did your intervention reach the target population?

What unintended consequences or outcomes might there be?

What unintended outcomes did you experience?

Adoption (#/% and representativeness of staff and sites who implemented the intervention)

How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia?

Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable.

Medical Assistant/ Provider

Who delivered the intervention? Did they have the skills and time needed to complete the intervention?

How will you know if clinicians/care teams/sites used the intervention?

provider two-question survey 

What proportion of the planned staff/sites implemented the intervention?

Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)?

Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention)

How will you know what adaptations or modifications were made during the intervention?

How did you track modifications during the intervention?

What might be some of the possible obstacles to consistent implementation? Capacity, health center merger

What were the barriers to consistent intervention implementation?

What costs and resources (including time and burden, not just money) need to be considered? EHR transition April 2024 Go live but prep will start several months before. Staff Capacity.

What costs and resources (including time and burden, not just money) need to be considered?

How closely did the staff/sites follow the intervention design and deliver as intended?

Check all that apply:

• Followed as designed
• Followed with minor modifications
• Followed somewhat as designed
• Not followed as design
• Delivered consistently/as intended
• Delivered somewhat consistently/somewhat as intended
• Delivered inconsistently/not as intended

Modifications made and other notes:

Maintenance (Extent to which intervention is part of routine practices and protocols)

What reinforcements will you put in place to sustain the intervention, if effective?

• Protocols
• Clinical decision support (alerts, order sets, templates, registries)
• Policies
• Regular training
• Regular reports
• Incentives
• Other:

Explain:

What reinforcements did you put into place to sustain the intervention?

• Protocols
• Clinical decision support (alerts, order sets, templates, registries)
• Policies
• Regular training
• Regular reports
• Incentives
• Other:

Explain:

How will you spread your intervention and lessons learned?

Internal health center meetings. Aliados Health peer network meetings.

How will you spread your intervention and lessons learned?

What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)?

Intervention #2

Plan

Intervention #2

Actual

Describe Intervention

Chosen intervention: ASCVD Risk calculator

Plan for intervention: Continue using IPads to expand beyond the pilot team at DCC to all provider teams at DCC by Dec 2023. Starting Mar 2024, we will roll out risk calculator tool (using IPads) to all provider teams at the remaining CCHC sites.

Chosen Intervention:

Date when implemented:

Updates:

Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention)

Reach of implementers/providers?

Planned: all sites, working on estimated number, probably more than intervention. 2-4 providers.

Reach of implementers/providers?

Actual:

Reach of patients?

Planned: 6 patients/day average per team

Reach of patients?

Actual:

Efficacy (Impact of intervention on important outcomes)

How will you measure that your intervention is working?

number of patients exposed to the risk tool and their understanding, including conversations with provider, what their cardiovascular disease risk means and steps to manage.

Were you able to accurately measure how your intervention was working?

What outcomes do you expect?

• regarding cardiovascular risk, we encourage patient autonomy by choosing their intervention from, (A) physical activity goal, (B) caloric intake goal (C) medication goal

What outcomes have you seen?

How will you ensure your intervention will be effective for your target population?

we believe patient-driven choice/participation will be more motivating to reduce risk than provider-driven.

Did your intervention reach the target population?

What unintended consequences or outcomes might there be?

we are hopeful the patient visit will be motivated to achieve positive change however the strategy chosen maybe something other than a statin.

What unintended outcomes did you experience?

Adoption (#/% and representativeness of staff and sites who implemented the intervention)

How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia?

Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable.

Providers, medical assistants

Who delivered the intervention? Did they have the skills and time needed to complete the intervention?

How will you know if clinicians/care teams/sites used the intervention?

What proportion of the planned staff/sites implemented the intervention?

Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)?

Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention)

How will you know what adaptations or modifications were made during the intervention?

How did you track modifications during the intervention?

What might be some of the possible obstacles to consistent implementation?

What were the barriers to consistent intervention implementation?

What costs and resources (including time and burden, not just money) need to be considered?

What costs and resources (including time and burden, not just money) need to be considered?

How closely did the staff/sites follow the intervention design and deliver as intended?

Check all that apply:

• Followed as designed
• Followed with minor modifications
• Followed somewhat as designed
• Not followed as design
• Delivered consistently/as intended
• Delivered somewhat consistently/somewhat as intended
• Delivered inconsistently/not as intended

Modifications made and other notes:

Maintenance (Extent to which intervention is part of routine practices and protocols)

What reinforcements will you put in place to sustain the intervention, if effective?

• Protocols
• Clinical decision support (alerts, order sets, templates, registries)
• Policies
• Regular training
• Regular reports
• Incentives
• Other:

Explain:

What reinforcements did you put into place to sustain the intervention?

• Protocols
• Clinical decision support (alerts, order sets, templates, registries)
• Policies
• Regular training
• Regular reports
• Incentives
• Other:

Explain:

How will you spread your intervention and lessons learned?

How will you spread your intervention and lessons learned?

What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)?